Association analysis of SCN9A gene variants with borderline personality disorder

Journal of Psychiatric Research

Volumn 43, Issue 2, 2008, Pages 155-163

  Tadić, André ^a   Baskaya, Ömur ^a   Victor, Anja ^a   Lieb, Klaus ^a   Höppner, Wolfgang ^b   Dahmen, Norbert ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Bioglobe GmbH   (Germany)

Author keywords

Borderline personality disorder; Candidate gene; Dissociation; Genetics; Haplotype; Nav1.7; SCN9A

Indexed keywords

ADULT; ARTICLE; BORDERLINE STATE; CONTROLLED STUDY; FEMALE; GENE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCN9A GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BORDERLINE PERSONALITY DISORDER; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SEX DISTRIBUTION;

EID: 53049099416     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.03.006     Document Type: Article

References (52)

1. Akhtar S., Byrne J.P., and Doghramji K. The demographic profile of borderline personality disorder. J Clin Psychiat 47 (1986) 196-198
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
3. American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiat 158 10 Suppl (2001) 1-52
4. Bernstein E.M., and Putnam F.W. Development, reliability, and validity of a dissociation scale. J Nerv Ment Disord 174 (1986) 727-735
5. Bohus M., Limberger M., Ebner U., Glocker F.X., Schwarz B., Wernz M., et al. Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior. Psychiat Res 95 (2000) 251-260
6. Brambilla P., Soloff P.H., Sala M., Nicoletti M.A., Keshavan M.S., and Soares J.C. Anatomical MRI study of borderline personality disorder patients. Psychiat Res 131 (2004) 125-133
7. Carlson E.B., Putnam F.W., Ross C.A., Torem M., Coons P., and Loewenstein R.J. Validity of the dissociative experiences scale: a multicenter study. Am J Psychiat 150 (1993) 1030-1036
8. Clarkin J.F., Widiger T.A., Frances A., Hurt S.W., and Gilmore M. Prototypic typology and the borderline personality disorder. J Abnorm Psychol 92 (1983) 263-275
9. Coid J., Yang M., Tyrer P., Roberts A., and Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Brit J Psychiat 188 (2006) 423-431
10. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 (2006) 894-898
11. Distel M.A., Trull T.J., Derom C.A., Thiery E.W., Grimmer M.A., Martin N.G., et al. Heritability of borderline personality disorder features is similar across three countries. Psychol Med (2007) 10.1017/S0033291707002024
12. Fertleman C.R., Baker M.D., Parker K.A., Moffatt S., Elmslie F.V., Abrahamsen B., et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52 (2006) 767-774
13. Freyberger H.J., Spitzer C., Stieglitz R.D., Kuhn G., Magdeburg N., and Bernstein-Carlson E. Questionnaire on dissociative symptoms. German adaptation, reliability and validity of the American Dissociative Experience Scale (DES). Psychother Psychosomat Medizin Psychol 48 (1998) 223-229
14. v1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Gen 71 (2007) 311-319
15. Irle E., Lange C., Weniger G., and Sachsse U. Size abnormalities of the superior parietal cortices are related to dissociation in borderline personality disorder. Psychiat Res 156 (2007) 139-149
16. Lenzenweger M.F., Lane M.C., Loranger A.W., and Kessler R.C. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiat 62 (2007) 553-564
17. Leyton M., Okazawa H., Diksic M., Paris J., Rosa P., Mzengeza S., et al. Brain regional alpha-[11C]methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiat 158 (2001) 775-782
18. Lieb K., Zanarini M.C., Schmahl C., Linehan M.M., and Bohus M. Borderline personality disorder. Lancet 364 (2004) 453-461
19. Ludäscher P., Bohus M., Lieb K., Philipsen A., Jochims A., and Schmahl C. Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiat Res 149 (2007) 291-296
20. Mechaly I., Scamps F., Chabbert C., Sans A., and Valmier J. Molecular diversity of voltage-gated sodium channel alpha-subunits expressed in neuronal and non-neuronal excitable cells. Neuroscience 130 (2005) 389-396
21. v1.7. Arch Neurol 62 (2005) 1587-1590
22. Nassar M.A., Stirling L.C., Forlani G., Baker M.D., Matthews E.A., Dickenson A.H., et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci USA 101 (2004) 12706-12711
23. Ni X., Chan K., Bulgin N., Sicard T., Bismil R., McMain S., et al. Association between serotonin transporter gene and borderline personality disorder. J Psychiat Res 40 (2006) 448-453
24. Ni X., Bismil R., Chan K., Sicard T., Bulgin N., McMain S., et al. Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder. Neurosci Lett 408 (2006) 214-219
25. Ni X., Sicard T., Bulgin N., Bismil R., Chan K., McMain S., et al. Monoamine oxidase A gene is associated with borderline personality disorder. Psychiat Gen 17 (2007) 153-157
26. Nigg J.T., and Goldsmith H.H. Genetics of personality disorders: perspectives from personality and psychopathology research. Psychol Bull 115 (1994) 346-380
27. Nijenhuis E.R., Spinhoven P., Van Dyck R., Van der Hart O., and Vanderlinden J. The development and psychometric characteristics of the somatoform dissociation questionnaire (SDQ-20). J Nerv Ment Disord 184 (1996) 688-694
28. Nijenhuis E.R., Spinhoven P., van Dyck R., van der Hart O., and Vanderlinden J. Psychometric characteristics of the somatoform dissociation questionnaire: a replication study. Psychother Psychosom 67 (1998) 17-23
29. Pascual J.C., Soler J., Barrachina J., Campins M.J., Alvarez E., Perez V., et al. Failure to detect an association between the serotonin transporter gene and borderline personality disorder. J Psychiat Res 42 (2008) 87-88
30. Raymond C.K., Castle J., Garrett-Engele P., Armour C.D., Kan Z., Tsinoremas N., et al. Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem 279 (2004) 46234-46241
31. Russ M.J., Roth S.D., Lerman A., Kakuma T., Harrison K., Shindledecker R.D., et al. Pain perception in self-injurious patients with borderline personality disorder. Biol Psychiat 32 (1992) 501-511
32. Russ M.J., Shearin E.N., Clarkin J.F., Harrison K., and Hull J.W. Subtypes of self-injurious patients with borderline personality disorder. Am J Psychiat 150 (1993) 1869-1871
33. Schmahl C., Greffrath W., Baumgartner U., Schlereth T., Magerl W., Philipsen A., et al. Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings. Pain 110 (2004) 470-479
34. Schmahl C., Bohus M., Esposito F., Treede R.D., Di Salle F., Greffrath W., et al. Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiat 63 (2006) 659-667
35. Soloff P.H., Kelly T.M., Strotmeyer S.J., Malone K.M., and Mann J.J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiat Res 119 (2003) 11-24
36. Spitzer C., Freyberger H.J., Stieglitz R.D., Carlson E.B., Kuhn B., Magdeburg N., et al. Adaptation and psychosomatic properties of the German version of the dissociative experiences scale. J Traum Stress 11 (1998) 799-809
37. Stein M.B., Koverola C., Hanna C., Torchia M.G., and McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 27 (1997) 951-959
38. Swartz M.S., Blazer D., Goerge L., and Winfield I. Estimating the prevalence of borderline personality disorder in the community. J Personal Disord 4 (1990) 257-272
39. Tebartz van Elst L., Hesslinger B., Thiel T., Geiger E., Haegele K., Lemieux L., et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiat 54 (2003) 163-171
40. Thalmeier A., Dickmann M., Giegling I., Schneider B., Hartmann A.M., Maurer K., et al. Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsychopharmacol 3 (2007) 1-12 [Epub ahead of print]
41. Toledo-Aral J.J., Moss B.L., He Z.J., Koszowski A.G., Whisenand T., Levinson S.R., et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 94 (1997) 1527-1532
42. Torgersen S., Lygren S., Oien P.A., Skre I., Onstad S., Edvardsen J., et al. A twin study of personality disorders. Comprehen Psychiat 41 (2000) 416-425
43. Torgersen S., Kringlen E., and Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiat 58 (2001) 590-596
44. Vermetten E., Schmahl C., Lindner S., Loewenstein R.J., and Bremner J.D. Hippocampal and amygdalar volumes in dissociative identity disorder. Am J Psychiat 163 (2006) 630-636
45. Weiss L.A., Escayg A., Kearney J.A., Trudeau M., MacDonald B.T., Mori M., et al. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiat 8 (2003) 186-194
46. Widiger T.A., and Trull T. Borderline and narcissistic personality disorders. In: Sutker P., and Adams H. (Eds). Comprehensive textbook of psychopathology. 2nd ed. (1993), Plenum, New York 371-394
47. Wittchen H.U., Zaudig M., and Fydrich T. SKID-I/-II: strukturiertes klinisches interview für DSM-IV (1996), Hogrefe, Göttingen
48. Wittchen H., Lachner G., Wunderlich U., and Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-composite international diagnostic interview (M-CIDI). Social Psychiat Psychiat Epidemiol 33 (1998) 568-578
49. World Health Organization (WHO). The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, Geneva; 1992.
50. Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Gen 41 (2004) 171-174
51. Zaboli G., Gizatullin R., Nilsonne A., Wilczek A., Jonsson E.G., Ahnemark E., et al. Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology 31 (2006) 1982-1990
52. Zetzsche T., Preuss U.W., Frodl T., Schmitt G., Seifert D., Munchhausen E., et al. Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiat Res 154 (2007) 157-170